|
2025
|
G/S
|
Pharmaceutical preparations and substances. |
|
|
G/S
|
Pharmaceutical preparations and substances for the treatment of cardiovascular, metabolic, and re... |
|
|
G/S
|
Pharmaceutical preparations and substances |
|
2024
|
G/S
|
Pharmaceutical preparations and substances. |
|
|
G/S
|
Pharmaceutical preparations and substances for the treatment of respiratory diseases and disorders |
|
|
G/S
|
Pharmaceutical preparations and substances for the treatment of respiratory diseases and disorders |
|
|
Invention
|
Pharmaceutical compositions comprising azd9291.
The present invention relates to pharmaceutical ... |
|
|
Invention
|
Amido heteroaromatic compounds.
The specification relates to compounds of Formula (I):
The spe... |
|
|
Invention
|
Pharmaceutical composition.
The invention concerns pharmaceutical compositions containing a hydr... |
|
|
Invention
|
2-(2,4,5-substituted-anilino)pyrimidine compounds.
The present invention relates to certain 2-(2... |
|
|
Invention
|
Methods for treating chronic obstructive pulmonary disease in an enhanced patient population usin... |
|
|
G/S
|
Pharmaceutical preparations and substances for use in oncology. |
|
|
G/S
|
Pharmaceutical preparations and substances for use in
oncology. |
|
|
Invention
|
Halo-substituted piperidines as orexin receptor modulators.
The present application relates to c... |
|
|
G/S
|
Pharmaceutical preparations for use in oncology; Pharmaceutical preparations and substances for t... |
|
|
Invention
|
Cd123 antibody-drug conjugates and methods of using the same. The present disclosure generally re... |
|
|
Invention
|
2,4,6-trisubstituted 1,3,5-triazines as modulators of cx3cr1.
There are disclosed certain 2,4,6-... |
|
|
Invention
|
Multivalent cargo-carrying complexes and uses thereof. Provided are multivalent saccharide-contai... |
|
|
Invention
|
Treatment of neurodegenerative diseases. The invention relates to a method of treating or prevent... |
|
|
Invention
|
Rsv vaccine.
Provided herein is a vaccine against RSV. The vaccine comprises an mRNA encoding a ... |
|
|
Invention
|
Rsv vaccine. Provided herein is a vaccine against RSV. The vaccine comprises an mRNA encoding a s... |
|
|
Invention
|
Chemical compounds.
The specification relates to compounds of Formula (I):
The specification r... |
|
|
Invention
|
Combination of zibotentan and dapagliflozin for the treatment of endothelin related diseases.
Th... |
|
|
Invention
|
Modified cell. Provided are hypoimmunogenic cells and methods of manufacturing such. |
|
|
Invention
|
Lilrb2 binding proteins and uses thereof. The present disclosure relates to binding proteins (e.g... |
|
|
Invention
|
Molecular switches. Provided herein are compositions and methods that permit the controlled inter... |
|
|
Invention
|
Tissue regeneration. Populations of cells for use in the treatment of kidney disease and methods ... |
|
|
Invention
|
3-[3-amino-6-(2-hydroxyphenyl)pyridazin-4-yl]-3,8-diazabicyclo[3.2.1]octane derivatives as smarca... |
|
|
Invention
|
Smarca2 degraders and uses thereof. The present disclosure provides compounds represented by Form... |
|
|
Invention
|
Armored t cells. This disclosure relates to compositions and methods for treating cancer using po... |
|
|
Invention
|
Pyrrolopyrimidine carboxamides. Pyrrolopyrimidine carboxamides and pharmaceutically acceptable sa... |
|
|
Invention
|
Methods, compositions, and combinations for the treatment of ovarian cancer. The disclosure relat... |
|
|
Invention
|
Pharmaceutical compositions. The present specification relates to pharmaceutical compositions com... |
|
|
Invention
|
Treatment of lupus. The disclosure relates to methods and compositions for the treatment of SLE. ... |
|
|
Invention
|
Methods and combinations for treating cervical cancer. The disclosure relates to methods, combina... |
|
|
Invention
|
Anti-ifnar1 dosing regime for subcutaneous injection.
The disclosure relates to methods and comp... |
|
|
Invention
|
Combination of a parp1 inhibitor and a selective estrogen degrader for treating cancer. A method ... |
|
|
Invention
|
Methods of treatment of chronic kidney disease. The application relates to methods of treating ch... |
|
|
Invention
|
Pseudomonas antibodies with modified fc regions and methods of use thereof. Pseudomonas aeruginos... |
|
|
Invention
|
Compositions and methods for treating late stage lung cancer.
Disclosed are methods for treating... |
|
|
G/S
|
Pharmaceutical preparations and substances for use in oncology |
|
|
G/S
|
Pharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and s... |
|
|
Invention
|
Combination of capivasertib, a cdk4/6 inhibitor and fulvestrant for use in the treatment of breas... |
|
|
G/S
|
Pharmaceutical preparations and substances for the treatment of respiratory diseases and disorders. |
|
|
Invention
|
Egfr tkis for use in the treatment of non-small lung cancer.
The specification relates to epider... |
|
|
Invention
|
Conjugates comprising cleavable linkers.
The specification relates to conjugates comprising a li... |
|
|
Invention
|
Conjugates comprising cleavable linkers. The specification relates to conjugates comprising a lin... |
|
|
Invention
|
Irak4 protacs.
This specification relates to compounds according to Formula (I), which are of PR... |
|
|
Invention
|
Compounds and their use.
The specification generally relates to compounds of Formula (I), and ph... |
|
|
G/S
|
Pharmaceutical preparations and substances for use in oncology. |
|
|
Invention
|
Dose.
The disclosure relates to methods and compositions for the treatment of type I IFN mediate... |
|
|
Invention
|
Compositions and methods for improving the efficacy of cas9-based knock-in strategies.
The prese... |
|
2023
|
Invention
|
Polq inhibitors.
The specification generally relates to compounds of Formula (I):
The specific... |
|
|
Invention
|
Use of inhibitors to increase efficiency of crispr/cas insertions.
The present disclosure provid... |
|
2022
|
Invention
|
Certain 3-azabicyclo[3.1.0]hexanes as glp-1 receptor modulators.
There are disclosed certain 3-a... |
|
|
Invention
|
Peptide dendrons and methods of use thereof.
The specification relates to peptide dendrons compr... |
|
|
Invention
|
Certain 2,5-diazabicyclo[4.2.0]octanes as glp-1 receptor modulators.
There are disclosed certain... |
|
|
Invention
|
Methods of treating inflammatory diseases with a selective glucocorticoid receptor modulator.
Th... |
|
|
Invention
|
Substituted pyrazine-2-carboxamides as hpk1 inhibitors for the treatment of cancer.
There are di... |
|
|
Invention
|
Devices and a system for detection and analysis of inhaler use.
Devices, methods and a system fo... |
|
|
Invention
|
Ca s9 effector proteins with enhanced stability.
Provided are Cas9 effector proteins having enha... |
